Title: Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
Agency/Subagency: 1117-DOJ/DEA
Stage of Rulemaking: Final Rule Stage
Meeting Date/Time: 05/02/2023 03:30 PM
Requestor: Foley & Lardner LLP Requestor's Name: Kate Kros Requestor's Client: QuickMD